Back to 
SUSQUEHANNA INTERNATIONAL GROUP, LLP
SUSQUEHANNA INTERNATIONAL GROUP, LLP
BCTXShowing 0 of 3 quarters
Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in BRIACELL THERAPEUTICS CORP
No. Susquehanna International Group exited its BCTX (Briacell Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 18,865 shares worth $121,113. Susquehanna International Group first reported BCTX in Q1 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BCTX: WASATCH ADVISORS LP, Hudson Bay Capital Management LP